Crossmark

Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)—a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndrome

Crossref DOI link: https://doi.org/10.1186/s13063-025-08825-7

Published Online: 2025-04-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stortz, Marco https://orcid.org/0000-0002-3838-2150
Klimpke, Pascal

Kommer, Andreas

Gründer, Philipp

Steenken, Livia

Dresel, Christian

Kraus, Daniel

Schmidtmann, Irene

Weinmann, Arndt

Weinmann-Menke, Julia
Funding

Funding for this research was provided by:

Universitätsmedizin der Johannes Gutenberg-Universität Mainz
License Information

Text and Data Mining valid from 2025-04-03

Version of Record valid from 2025-04-03
More Information

Article History

Received: 25 January 2024

Accepted: 24 March 2025

First Online: 3 April 2025

Declarations

:

: Permission of the ethics committee of the medical association of Rhineland-Palatine was given (2022–16804 andere Forschung erstvotierend). The study will be conducted according to standards of the Declaration of Helsinki. Written informed consent to participate will be obtained from all participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below